Skip to main content
. 2024 Jun 26;16:135. doi: 10.1186/s13195-024-01497-6

Table 2.

Significant predictors of future memory function

Baseline predictor a Univariate models b Basic models c Multivariable model d
β (95% CI) β (95% CI) β (95% CI)
Age -0.16 (-0.19 – -0.12)*** -0.17 (-0.20 – -0.13)***

-0.14

(-0.18 – -0.10)***

Alcohol consumption e

Q1 (≤ 0.23 standard drinks/day)

Q2 (0.24–0.56 standard drinks/day)

Q3 (0.57–1.01 standard drinks/day)

Q4 (≥ 1.02 standard drinks/day)

Reference

0.12 (0.02–0.21)*

0.15 (0.05–0.25)**

0.14 (0.04–0.23)**

Reference

0.06 (-0.04–0.17)

0.11 (0.00–0.21)*

0.11 (-0.00–0.22)

Reference

0.10 (-0.01–0.20)

0.12 (0.00– 0.23)*

0.13 (0.01–0.24)*

APOE genotype

ɛ3/ɛ3

ɛ2/ɛ2 or ɛ2/ ɛ3

ɛ2/ɛ4

ɛ3/ɛ4 or ɛ4/ɛ4

Reference

-0.01 (-0.12–0.09)

-0.02 (-0.25–0.20)

-0.13 (-0.21 – -0.04)**

Reference

0.03 (-0.08–0.14)

0.02 (-0.22 – 0.25)

-0.12 (-0.21 – -0.04)**

Reference

0.03 (-0.08–0.15)

0.01 (-0.23–0.25)

-0.14 (-0.23 – -0.05)**

BMI -0.08 (-0.11 – -0.04)*** -0.04 (-0.08 – -0.00)* -0.01 (-0.05–0.03)
Diabetes f -0.36 (-0.51 – -0.21)*** -0.29 (-0.44 – -0.13)*** Not included g
Education

≤8 years

9–12 years

>12 years

Reference

0.25 (0.17–0.33)***

0.42 (0.33–0.51)***

Reference

0.21 (0.12–0.29)***

0.36 (0.27–0.46)***

Reference

0.17 (0.08–0.26)***

0.32 (0.21–0.42)***

Glucose (plasma) -0.10 (-0.14 – -0.07)*** -0.09 (-0.12 – -0.05)*** Not included g
HbA 1c -0.11 (-0.14 – -0.07)*** -0.07 (-0.11 – -0.04)*** -0.08 (-0.12 – -0.04)***
HDL-C 0.09 (0.06–0.13)*** 0.06 (0.02–0.11)** 0.03 (-0.02–0.08)
Sex (0 = men, 1 = women) 0.24 (0.17–0.31)*** 0.24 (0.17 − 0.32) *** 0.23 (0.14–0.32)***
Systolic blood pressure -0.11 (-0.14 – -0.07)*** -0.04 (-0.08 – -0.00)* -0.03 (-0.07–0.01)
Triglycerides -0.10 (-0.14 – -0.06)*** -0.05 (-0.10 – -0.01)* -0.01 (-0.07–0.04)

Only predictors that were significant in the basic model are shown in Table 2. The predictors that were non-significant in the basic model are shown in eTable 1 and included: Carotid stenosis, hypertension, LDL-C, physical activity, prevalent or incident stroke and smoking. Predictors in bold represent the significant predictors from the multivariable model

a All continuous variables used as z-scores (i.e., not alcohol, APOE, diabetes, education, hypertension and sex)

b Including only the predictor and time between baseline and follow-up

c Including the predictor adjusted for age, sex, education, time between baseline and follow-up, and prevalent or incident stroke

d One model combining all significant predictors from the basic models, adjusted for age, sex, education, time between baseline and follow-up, prevalent or incident stroke and blood lipid lowering medication

e Alcohol consumption in quartiles with lowest quartile as reference: Q1 ≤ 0.23 standard drinks/day (0–3.37 g/day); Q2 0.24–0.56 standard drinks/day (3.38–7.83 g/day); Q3 0.57–1.01 standard drinks/day (7.84–15.2 g/day); Q4 ≥ 1.02 standard drinks/day, (≥ 15.3 g/day)

f Defined as a diabetes diagnosis entered in the baseline questionnaire or having fasting plasma glucose levels > 6mmol/L at baseline

g To avoid collinearity issues, HbA1c, diabetes, and plasma glucose levels were not entered in the same model (only HbA1c in the multivariable model)

* p < 0.05, ** p < 0.01, *** p < 0.001